RBC Capital upgraded Fisher & Paykel Healthcare to Sector Perform from Underperform with a price target of NZ$23, up from NZ$20. The analyst cites stronger than expected demand for hospital consumables for the upgrade.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FSPKF:
